Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH) [NA]

View source ↗

Summary

This clinical trial update reports termination of a study evaluating guanfacine for reversing opioid-induced hyperalgesia in individuals with Chronic Pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Chronic Pain | NA | Status: TERMINATED